Uncategorized

AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data

Published

on

Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version